Skip to main navigation
Skip to search
Skip to main content
Vrije Universiteit Brussel Home
Help & FAQ
English
Nederlands
Home
Research units
Profiles
Projects
Research output
Activities
Equipment
Prizes
Press/Media
Student theses
Datasets
Impacts
Search by expertise, name or affiliation
Prijs Kankeronderzoek 2016 - Startersbeurs tbv Y. De Vlaeminck
Breckpot, Karine
(Administrative Promotor)
Basic (bio-) Medical Sciences
Overview
Fingerprint
Research output
(1)
Project Details
Description
Prijs Kankeronderzoek 2016 - Startersbeurs Yannick De Vlaeminck
Short title or EU acronym
Prijs Kankeronderzoek
Acronym
OZR3007
Status
Finished
Effective start/end date
10/08/16
→
10/08/20
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Single-Domain Antibodies
Medicine & Life Sciences
100%
Neuropilin-1
Medicine & Life Sciences
50%
mannose receptor
Medicine & Life Sciences
48%
Mannose
Chemistry
36%
Macrophages
Medicine & Life Sciences
34%
Colorectal Neoplasms
Medicine & Life Sciences
26%
Neoplasms
Medicine & Life Sciences
19%
Semaphorin-3A
Medicine & Life Sciences
17%
Research output
Research output per year
2019
2019
2019
1
Article
Research output per year
Research output per year
Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophages
De Vlaeminck, Y.
,
Lecocq, Q.
,
Giron, P.
,
Geeraerts, X.
,
Schoonooghe, S.
,
Movahedi, K.
,
Massa, S.
,
Bolli, E.
,
Goyvaerts, C.
,
Van Ginderachter, J.
&
Breckpot, K.
,
10 Apr 2019
,
In:
Journal of Controlled Release.
299
,
2
,
p. 107-120
14 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Single-Domain Antibodies
100%
mannose receptor
96%
Mannose
73%
Macrophages
47%
Protein
27%
16
Citations (Scopus)
376
Downloads (Pure)